Filing Flows › HeartSciences (HSCS) › Q1 FY27 › vs Q1 FY26
HeartSciences (HSCS) Q1 FY27 vs Q1 FY26 (year over year)
HeartSciences's revenue rose $200 (+11%) from $2K in Q1 FY26 to $2K in Q1 FY27.
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $2K | $2K | $200 | +11% |
| Net loss | $3.2M | $2.1M | $1.1M | +54% |
| Costs & expenses | $3.2M | $2.1M | $1.1M | +54% |
| Operating costs | $2.9M | $1.9M | $1.1M | +57% |
| Interest & other, net | $233K | $181K | $52K | +29% |
| Cost of revenue | $1K | $1K | $0 | 0% |
| Research & development | $907K | $997K | −$91K | -9% |
| SG&A | $2.0M | $878K | $1.2M | +132% |
| Operating cash sources | $3.2M | $2.1M | $1.1M | +54% |
| Depreciation | $6K | $7K | −$1K | -11% |
| Share-based compensation | $739K | $175K | $564K | +323% |
| Working capital & other | $1.1M | −$80K | $1.2M | — |
| Cash used in operations | $1.3M | $2.0M | −$635K | -32% |
| Net loss absorbed | $3.2M | $2.1M | $1.1M | +54% |
Questions
How much did HeartSciences's revenue grow year over year in Q1 FY27?
HeartSciences's revenue rose $200 (+11%) from $2K in Q1 FY26 to $2K in Q1 FY27.